PMID- 36401264
OWN - NLM
STAT- MEDLINE
DCOM- 20221122
LR  - 20221122
IS  - 2662-7671 (Electronic)
IS  - 2662-7671 (Linking)
VI  - 22
IP  - 1
DP  - 2022 Nov 18
TI  - Safety of acupuncture by Korean Medicine Doctors: a prospective, practice-based 
      survey of 37,490 consultations.
PG  - 300
LID - 10.1186/s12906-022-03782-z [doi]
LID - 300
AB  - BACKGROUND: To evaluate safety of acupuncture treatment by Korean Medicine 
      Doctors (KMDs), a prospective, practice-based survey on adverse events (AEs) 
      associated with acupuncture was conducted. METHODS: From July 2016 to October 
      2017, KMDs were invited to participate in an online survey. Frequency was 
      calculated as the number of AEs per 10,000 treatments; severity was assessed with 
      the Common Terminology Criteria for Adverse Events Grading (Severity) Scale; and 
      causality was evaluated using the World Health Organisation-Uppsala Monitoring 
      Centre system for standardised case causality assessment. Associations between AE 
      occurrence and KMDs' type of practice/clinical experience and patient 
      age/gender/current medication(s) were analysed. RESULTS: Data on 37,490 
      acupuncture treatments were collected from 222 KMDs. At least one AE was reported 
      from 4,518 acupuncture treatments, giving a frequency rate of 1,205 per 10,000 
      acupuncture treatments; this increased to 4,768 treatments when administrative 
      problems related to defective devices or medical negligence were added, for a 
      rate of 1,272 per 10,000 acupuncture treatments. Commonly reported AEs were 
      bleeding, needle site pain, and bruising. Approximately 72.9% of 
      AEs/administrative problems were assessed as they certainly occurred by 
      acupuncture treatment in causality assessment. Most AEs/administrative problems 
      were considered mild in severity and two life-threatening AEs were resolved with 
      no sequelae. Compared to males, female patients were more likely to experience 
      AEs and KMDs' clinical experience was not associated with reported AE occurrence. 
      CONCLUSIONS: Although acupuncture-associated AEs occur commonly, they are largely 
      transient and mild. Acupuncture performed by qualified KMDs may serve as a 
      reliable medical treatment with acceptable safety profiles.
CI  - (c) 2022. The Author(s).
FAU - Won, Jiyoon
AU  - Won J
AUID- ORCID: 0000-0002-4759-3865
AD  - KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, 
      Korea.
FAU - Lee, Jun-Hwan
AU  - Lee JH
AUID- ORCID: 0000-0001-5730-6869
AD  - KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, 
      Korea.
AD  - Korean Convergence Medical Science, KIOM School, University of Science & 
      Technology (UST), Daejeon, Korea.
FAU - Bang, Heejung
AU  - Bang H
AUID- ORCID: 0000-0002-5755-9951
AD  - Division of Biostatistics, Department of Public Health Sciences, University of 
      California, Davis, CA, USA.
FAU - Lee, Hyangsook
AU  - Lee H
AUID- ORCID: 0000-0002-1107-9389
AD  - Acupuncture & Meridian Science Research Centre, College of Korean Medicine, Kyung 
      Hee University, Seoul, Korea. erc633@khu.ac.kr.
AD  - Department of Science in Korean Medicine, College of Korean Medicine, Graduate 
      School, Kyung Hee University, Seoul, Korea. erc633@khu.ac.kr.
LA  - eng
GR  - K17121/Korea Institute of Oriental Medicine/
GR  - NRF-2020R1A6A6017334/National Research Foundation of Korea/
PT  - Journal Article
DEP - 20221118
PL  - England
TA  - BMC Complement Med Ther
JT  - BMC complementary medicine and therapies
JID - 101761232
SB  - IM
MH  - Humans
MH  - Male
MH  - Female
MH  - Prospective Studies
MH  - *Acupuncture Therapy/adverse effects
MH  - Surveys and Questionnaires
MH  - Referral and Consultation
MH  - Republic of Korea
PMC - PMC9675262
OTO - NOTNLM
OT  - Acupuncture
OT  - Adverse events
OT  - Causality
OT  - Frequency
OT  - Korean Medicine Doctor
OT  - Safety
OT  - Severity
COIS- The authors declare that they have no competing interests.
EDAT- 2022/11/20 06:00
MHDA- 2022/11/23 06:00
PMCR- 2022/11/18
CRDT- 2022/11/19 00:09
PHST- 2022/06/02 00:00 [received]
PHST- 2022/10/17 00:00 [accepted]
PHST- 2022/11/19 00:09 [entrez]
PHST- 2022/11/20 06:00 [pubmed]
PHST- 2022/11/23 06:00 [medline]
PHST- 2022/11/18 00:00 [pmc-release]
AID - 10.1186/s12906-022-03782-z [pii]
AID - 3782 [pii]
AID - 10.1186/s12906-022-03782-z [doi]
PST - epublish
SO  - BMC Complement Med Ther. 2022 Nov 18;22(1):300. doi: 10.1186/s12906-022-03782-z.